Moleculin Biotech Inc

NASDAQ:MBRX   3:59:51 PM EDT
3.02
-0.08 (-2.58%)
Debt Financing / Related, Regulatory

Moleculin Biotech Inc Says On June 15, Co Entered Into An Amendment No. 4 To Patent And Technology License Agreement

Published: 06/21/2021 21:20 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Biotech Inc - on June 15, 2021,entered Into an Amendment No. 4 to Patent and Technology License Agreement Dated April 2, 2012.
Moleculin Biotech - Amendment Changes Requirement by Saying Co Can Satisfy Requirement by Filing Equivalent of Ind Application in Uk, India Before Aug 20.
Moleculin - Amendment Changes Requirement by Saying Co Can Satisfy Requirement by Filing Equivalent of Ind Application in Australia, Brazil Before Aug 20.